Document is current

Article History

Received: 13 July 2021

Accepted: 7 February 2022

First Online: 15 March 2022

Declarations

:

: The authors declare that they don’t have any conflict of interest.

: The study was reviewed and approved by the ethical committee of Biology department, Dilla University, Dilla, Ethiopia. Ethical considerations were addressed by treating positive intestinal protozoa by giving the drug of choice freely under the prescription and clinical supervision by an authorized health professionals at study sites. The permission has been obtained from Gesuba town primary hospital for sample collection. The questionnaires concerning the prevalence study were filled during sample collection. Written consent was obtained from participants working in different establishments. Apart from these, respondents were asked to fill the questionnaire and assist during sample collection. The information obtained during course of study was kept confidential. Paper data were kept in a locked cabinet confidentially and computer based data were secured with passwords. Except the research team members, no one could access patient data.

: Not applicable.